Area of research
Infectious Diseases · Hepatology
Research interest
Research focused on Hepatocellular carcinoma and Multiplex, with related work in Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Blockade, Immunotherapy. Notable publications include 'Epidemiology of COVID‐19: A systematic review and meta‐analysis of clinical characteristics, risk factors, and outcomes', 'Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy', and 'Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19'.
Global treatment rate and barriers to direct‐acting antiviral therapy: A systematic review and meta‐analysis of 146 studies and 1 760 352 hepatitis C virus patients
Global and regional long‐term survival following resection for HCC in the recent decade: A meta‐analysis of 110 studies
Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19
Intratumoral CD39+CD8+ T Cells Predict Response to Programmed Cell Death Protein-1 or Programmed Death Ligand-1 Blockade in Patients With NSCLC
Epidemiology of COVID‐19: A systematic review and meta‐analysis of clinical characteristics, risk factors, and outcomes
Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy
Transcriptional Spatial Profiling of Cancer Tissues in the Era of Immunotherapy: The Potential and Promise